

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * daunorubicin metabolic process (GO:0044597) | 4.42177702 |
| 2 | * polyketide metabolic process (GO:0030638) | 4.42177702 |
| 3 | * doxorubicin metabolic process (GO:0044598) | 4.42177702 |
| 4 | protein maturation by protein folding (GO:0022417) | 4.26827500 |
| 5 | nucleobase-containing small molecule interconversion (GO:0015949) | 4.26311159 |
| 6 | establishment of integrated proviral latency (GO:0075713) | 4.20441861 |
| 7 | proteasome assembly (GO:0043248) | 4.18574334 |
| 8 | pentose-phosphate shunt (GO:0006098) | 4.10290687 |
| 9 | NADPH regeneration (GO:0006740) | 4.03392795 |
| 10 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.00999727 |
| 11 | * aminoglycoside antibiotic metabolic process (GO:0030647) | 3.95560867 |
| 12 | negative regulation of ligase activity (GO:0051352) | 3.85964284 |
| 13 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.85964284 |
| 14 | regulation of mitochondrial translation (GO:0070129) | 3.76365394 |
| 15 | establishment of viral latency (GO:0019043) | 3.75619035 |
| 16 | cullin deneddylation (GO:0010388) | 3.71900649 |
| 17 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.68410630 |
| 18 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.67545396 |
| 19 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.67217210 |
| 20 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.64627122 |
| 21 | protein deneddylation (GO:0000338) | 3.62144788 |
| 22 | DNA strand elongation (GO:0022616) | 3.57650693 |
| 23 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.50848949 |
| 24 | IMP biosynthetic process (GO:0006188) | 3.49414246 |
| 25 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.42039593 |
| 26 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.33281263 |
| 27 | purine nucleobase biosynthetic process (GO:0009113) | 3.28138424 |
| 28 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.25042273 |
| 29 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.24093833 |
| 30 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.21486755 |
| 31 | ribosome assembly (GO:0042255) | 3.21221473 |
| 32 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.19401165 |
| 33 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.19401165 |
| 34 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.19202922 |
| 35 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.19202922 |
| 36 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.19202922 |
| 37 | glucose catabolic process (GO:0006007) | 3.16685710 |
| 38 | nuclear envelope reassembly (GO:0031468) | 3.16041564 |
| 39 | mitotic nuclear envelope reassembly (GO:0007084) | 3.16041564 |
| 40 | IMP metabolic process (GO:0046040) | 3.13407908 |
| 41 | nucleobase biosynthetic process (GO:0046112) | 3.12637843 |
| 42 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.12406309 |
| 43 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.11822514 |
| 44 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.11822514 |
| 45 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.05649406 |
| 46 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.05077967 |
| 47 | COPI coating of Golgi vesicle (GO:0048205) | 3.03603058 |
| 48 | Golgi transport vesicle coating (GO:0048200) | 3.03603058 |
| 49 | positive regulation of ligase activity (GO:0051351) | 3.03485778 |
| 50 | regulation of translational termination (GO:0006449) | 3.00195658 |
| 51 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.96840598 |
| 52 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.93590631 |
| 53 | cell adhesion mediated by integrin (GO:0033627) | 2.91984354 |
| 54 | regulation of ligase activity (GO:0051340) | 2.89981347 |
| 55 | DNA replication checkpoint (GO:0000076) | 2.89150138 |
| 56 | tricarboxylic acid cycle (GO:0006099) | 2.88263999 |
| 57 | L-serine metabolic process (GO:0006563) | 2.85792195 |
| 58 | purine nucleotide salvage (GO:0032261) | 2.85089351 |
| 59 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.84097769 |
| 60 | pentose metabolic process (GO:0019321) | 2.83410161 |
| 61 | mitotic metaphase plate congression (GO:0007080) | 2.82007598 |
| 62 | ventricular cardiac muscle cell development (GO:0055015) | 2.80942606 |
| 63 | glucose 6-phosphate metabolic process (GO:0051156) | 2.77689387 |
| 64 | AMP metabolic process (GO:0046033) | 2.76587923 |
| 65 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.75832872 |
| 66 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.74274615 |
| 67 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.74027360 |
| 68 | type B pancreatic cell proliferation (GO:0044342) | 2.73221611 |
| 69 | protein hydroxylation (GO:0018126) | 2.72877743 |
| 70 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.72109075 |
| 71 | DNA unwinding involved in DNA replication (GO:0006268) | 2.71970301 |
| 72 | chaperone-mediated protein transport (GO:0072321) | 2.71610733 |
| 73 | protein targeting to mitochondrion (GO:0006626) | 2.71344442 |
| 74 | protein heterotetramerization (GO:0051290) | 2.69944942 |
| 75 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.68472869 |
| 76 | ATP synthesis coupled proton transport (GO:0015986) | 2.68472869 |
| 77 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.66582497 |
| 78 | peptidyl-proline hydroxylation (GO:0019511) | 2.65251602 |
| 79 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.64728579 |
| 80 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.62989451 |
| 81 | cyclooxygenase pathway (GO:0019371) | 2.60863085 |
| 82 | protein retention in ER lumen (GO:0006621) | 2.60428220 |
| 83 | establishment of protein localization to mitochondrion (GO:0072655) | 2.59682028 |
| 84 | positive regulation of cell cycle arrest (GO:0071158) | 2.59334851 |
| 85 | regulation of cellular amine metabolic process (GO:0033238) | 2.58019007 |
| 86 | negative regulation of protein ubiquitination (GO:0031397) | 2.57818283 |
| 87 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.56557050 |
| 88 | cell cycle G1/S phase transition (GO:0044843) | 2.56557050 |
| 89 | telomere maintenance via recombination (GO:0000722) | 2.55488575 |
| 90 | spliceosomal snRNP assembly (GO:0000387) | 2.54788249 |
| 91 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.54437987 |
| 92 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.54437987 |
| 93 | mitotic chromosome condensation (GO:0007076) | 2.54306662 |
| 94 | formation of translation preinitiation complex (GO:0001731) | 2.51565591 |
| 95 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.51341601 |
| 96 | ribosomal large subunit biogenesis (GO:0042273) | 2.51154116 |
| 97 | de novo protein folding (GO:0006458) | 2.48857835 |
| 98 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.48641682 |
| 99 | glycolytic process (GO:0006096) | 2.47750926 |
| 100 | chromatin remodeling at centromere (GO:0031055) | 2.47570280 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.40437511 |
| 2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.00992885 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.92313574 |
| 4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.85070973 |
| 5 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.49065357 |
| 6 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.24758551 |
| 7 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.10488435 |
| 8 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.99163918 |
| 9 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.95845849 |
| 10 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.93119579 |
| 11 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.81282156 |
| 12 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.77762807 |
| 13 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.61238566 |
| 14 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.54162261 |
| 15 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.49093646 |
| 16 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.48109928 |
| 17 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.48081312 |
| 18 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.43725261 |
| 19 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.41665846 |
| 20 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.41132787 |
| 21 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.37610219 |
| 22 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.37524936 |
| 23 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.22818096 |
| 24 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.14534707 |
| 25 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.07702883 |
| 26 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.05555423 |
| 27 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.05069301 |
| 28 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.01786686 |
| 29 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 2.01394804 |
| 30 | * E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.01206828 |
| 31 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.00232834 |
| 32 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.97436663 |
| 33 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.96591345 |
| 34 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.95160103 |
| 35 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.94927135 |
| 36 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.88032680 |
| 37 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.87529907 |
| 38 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.86528844 |
| 39 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.85380895 |
| 40 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.81917694 |
| 41 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.74016329 |
| 42 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.71385923 |
| 43 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.70154039 |
| 44 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.70066625 |
| 45 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.65958978 |
| 46 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.61944490 |
| 47 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.58279324 |
| 48 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.49522011 |
| 49 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.48924008 |
| 50 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.48834760 |
| 51 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.48091776 |
| 52 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.46550325 |
| 53 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.46054043 |
| 54 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.41448571 |
| 55 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.40050904 |
| 56 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.38775676 |
| 57 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.35252289 |
| 58 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.33957265 |
| 59 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.32347440 |
| 60 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.28894236 |
| 61 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.28629140 |
| 62 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.25803894 |
| 63 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.25697670 |
| 64 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.24921967 |
| 65 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.24385402 |
| 66 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.21712846 |
| 67 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.20607662 |
| 68 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.18612008 |
| 69 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.18557544 |
| 70 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.17974238 |
| 71 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.17808734 |
| 72 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.17221237 |
| 73 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.16909115 |
| 74 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.16518019 |
| 75 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.15822719 |
| 76 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.15018657 |
| 77 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.13951982 |
| 78 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.12416441 |
| 79 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.11089800 |
| 80 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.10036105 |
| 81 | ATF3_27146783_Chip-Seq_COLON_Human | 1.08631688 |
| 82 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.08594881 |
| 83 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.08411327 |
| 84 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.07334235 |
| 85 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.05705862 |
| 86 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.05681048 |
| 87 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 1.04983033 |
| 88 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.02871826 |
| 89 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01796826 |
| 90 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.01468290 |
| 91 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.00890873 |
| 92 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.98243220 |
| 93 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97408877 |
| 94 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.97374959 |
| 95 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.96930731 |
| 96 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96385712 |
| 97 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.93346805 |
| 98 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.93117031 |
| 99 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.92111675 |
| 100 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.92053530 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 3.42664384 |
| 2 | MP0003806_abnormal_nucleotide_metabolis | 3.16200653 |
| 3 | MP0003186_abnormal_redox_activity | 2.93355566 |
| 4 | MP0004272_abnormal_basement_membrane | 2.88779197 |
| 5 | MP0003950_abnormal_plasma_membrane | 2.83365266 |
| 6 | MP0010030_abnormal_orbit_morphology | 2.62048166 |
| 7 | MP0000751_myopathy | 2.57129572 |
| 8 | MP0005623_abnormal_meninges_morphology | 2.51354659 |
| 9 | MP0009379_abnormal_foot_pigmentation | 2.47122746 |
| 10 | MP0008007_abnormal_cellular_replicative | 2.40448105 |
| 11 | MP0003111_abnormal_nucleus_morphology | 2.38065057 |
| 12 | MP0008932_abnormal_embryonic_tissue | 2.34321416 |
| 13 | MP0010094_abnormal_chromosome_stability | 2.29753193 |
| 14 | MP0000749_muscle_degeneration | 2.24925034 |
| 15 | MP0004957_abnormal_blastocyst_morpholog | 2.19190402 |
| 16 | MP0004233_abnormal_muscle_weight | 2.19151353 |
| 17 | MP0005257_abnormal_intraocular_pressure | 2.13122236 |
| 18 | MP0000750_abnormal_muscle_regeneration | 2.08436767 |
| 19 | MP0002877_abnormal_melanocyte_morpholog | 2.06684560 |
| 20 | MP0003705_abnormal_hypodermis_morpholog | 2.02170233 |
| 21 | MP0003693_abnormal_embryo_hatching | 1.96600813 |
| 22 | MP0003077_abnormal_cell_cycle | 1.92358546 |
| 23 | MP0008058_abnormal_DNA_repair | 1.81874831 |
| 24 | MP0003941_abnormal_skin_development | 1.81665033 |
| 25 | MP0000358_abnormal_cell_content/ | 1.76147408 |
| 26 | MP0001348_abnormal_lacrimal_gland | 1.72292464 |
| 27 | MP0005023_abnormal_wound_healing | 1.69144536 |
| 28 | MP0003566_abnormal_cell_adhesion | 1.68635902 |
| 29 | MP0005197_abnormal_uvea_morphology | 1.67729339 |
| 30 | MP0005330_cardiomyopathy | 1.66460204 |
| 31 | MP0006036_abnormal_mitochondrial_physio | 1.61889516 |
| 32 | MP0000343_altered_response_to | 1.57924481 |
| 33 | MP0005058_abnormal_lysosome_morphology | 1.56513505 |
| 34 | MP0009053_abnormal_anal_canal | 1.52554430 |
| 35 | MP0010368_abnormal_lymphatic_system | 1.52537329 |
| 36 | MP0001661_extended_life_span | 1.52191521 |
| 37 | MP0006035_abnormal_mitochondrial_morpho | 1.50426158 |
| 38 | MP0000762_abnormal_tongue_morphology | 1.48272513 |
| 39 | MP0002295_abnormal_pulmonary_circulatio | 1.45707029 |
| 40 | MP0002269_muscular_atrophy | 1.44446171 |
| 41 | MP0001542_abnormal_bone_strength | 1.42498188 |
| 42 | MP0009697_abnormal_copulation | 1.41475810 |
| 43 | MP0000579_abnormal_nail_morphology | 1.35584352 |
| 44 | MP0003786_premature_aging | 1.32023611 |
| 45 | MP0003279_aneurysm | 1.28283269 |
| 46 | MP0001299_abnormal_eye_distance/ | 1.24278924 |
| 47 | MP0009840_abnormal_foam_cell | 1.23282330 |
| 48 | MP0005165_increased_susceptibility_to | 1.23012951 |
| 49 | MP0001730_embryonic_growth_arrest | 1.22205305 |
| 50 | MP0004858_abnormal_nervous_system | 1.20002265 |
| 51 | MP0005508_abnormal_skeleton_morphology | 1.19916285 |
| 52 | MP0005193_abnormal_anterior_eye | 1.16942690 |
| 53 | MP0003091_abnormal_cell_migration | 1.16835264 |
| 54 | MP0000759_abnormal_skeletal_muscle | 1.15971115 |
| 55 | MP0000350_abnormal_cell_proliferation | 1.14229762 |
| 56 | MP0002060_abnormal_skin_morphology | 1.14005565 |
| 57 | MP0000747_muscle_weakness | 1.13005514 |
| 58 | MP0008775_abnormal_heart_ventricle | 1.10983172 |
| 59 | MP0000049_abnormal_middle_ear | 1.09089431 |
| 60 | MP0001243_abnormal_dermal_layer | 1.08006237 |
| 61 | MP0002837_dystrophic_cardiac_calcinosis | 1.04196749 |
| 62 | MP0009250_abnormal_appendicular_skeleto | 1.03694944 |
| 63 | MP0001849_ear_inflammation | 1.00284512 |
| 64 | MP0002332_abnormal_exercise_endurance | 0.99556788 |
| 65 | MP0005332_abnormal_amino_acid | 0.97890359 |
| 66 | MP0005503_abnormal_tendon_morphology | 0.95901928 |
| 67 | MP0002972_abnormal_cardiac_muscle | 0.95166651 |
| 68 | MP0002697_abnormal_eye_size | 0.95149444 |
| 69 | MP0002102_abnormal_ear_morphology | 0.94258346 |
| 70 | MP0002080_prenatal_lethality | 0.91647199 |
| 71 | MP0010386_abnormal_urinary_bladder | 0.91640865 |
| 72 | MP0000733_abnormal_muscle_development | 0.91377224 |
| 73 | MP0010352_gastrointestinal_tract_polyps | 0.89980877 |
| 74 | MP0004087_abnormal_muscle_fiber | 0.85323444 |
| 75 | MP0005595_abnormal_vascular_smooth | 0.84669884 |
| 76 | MP0006054_spinal_hemorrhage | 0.84509214 |
| 77 | MP0002177_abnormal_outer_ear | 0.83502986 |
| 78 | MP0001853_heart_inflammation | 0.82489772 |
| 79 | MP0000013_abnormal_adipose_tissue | 0.82473340 |
| 80 | MP0003755_abnormal_palate_morphology | 0.81945813 |
| 81 | MP0003385_abnormal_body_wall | 0.81856282 |
| 82 | MP0004084_abnormal_cardiac_muscle | 0.81576792 |
| 83 | MP0005384_cellular_phenotype | 0.80454150 |
| 84 | MP0002938_white_spotting | 0.79823092 |
| 85 | MP0009384_cardiac_valve_regurgitation | 0.78977273 |
| 86 | MP0002234_abnormal_pharynx_morphology | 0.78440266 |
| 87 | MP0004036_abnormal_muscle_relaxation | 0.76522863 |
| 88 | MP0001958_emphysema | 0.75524471 |
| 89 | MP0005621_abnormal_cell_physiology | 0.75065595 |
| 90 | MP0000003_abnormal_adipose_tissue | 0.74979372 |
| 91 | MP0008875_abnormal_xenobiotic_pharmacok | 0.73694965 |
| 92 | MP0002085_abnormal_embryonic_tissue | 0.72577725 |
| 93 | MP0003718_maternal_effect | 0.71775603 |
| 94 | MP0000163_abnormal_cartilage_morphology | 0.71479851 |
| 95 | MP0001697_abnormal_embryo_size | 0.71294726 |
| 96 | MP0002106_abnormal_muscle_physiology | 0.71228700 |
| 97 | MP0005620_abnormal_muscle_contractility | 0.70342381 |
| 98 | MP0005369_muscle_phenotype | 0.68394038 |
| 99 | MP0004510_myositis | 0.65147930 |
| 100 | MP0000313_abnormal_cell_death | 0.65010330 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vertebral compression fractures (HP:0002953) | 4.62793129 |
| 2 | Ankle contracture (HP:0006466) | 4.28813087 |
| 3 | Premature rupture of membranes (HP:0001788) | 3.79132024 |
| 4 | Protrusio acetabuli (HP:0003179) | 3.65011994 |
| 5 | Abnormality of glycolysis (HP:0004366) | 3.41904708 |
| 6 | Increased serum pyruvate (HP:0003542) | 3.10172647 |
| 7 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.10070630 |
| 8 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.08734094 |
| 9 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.08734094 |
| 10 | Rough bone trabeculation (HP:0100670) | 2.95095325 |
| 11 | Acute necrotizing encephalopathy (HP:0006965) | 2.89889775 |
| 12 | Hepatocellular necrosis (HP:0001404) | 2.86510866 |
| 13 | Type 1 muscle fiber predominance (HP:0003803) | 2.84561945 |
| 14 | Testicular atrophy (HP:0000029) | 2.74592656 |
| 15 | Cervical subluxation (HP:0003308) | 2.71567211 |
| 16 | Spinal rigidity (HP:0003306) | 2.68682190 |
| 17 | Selective tooth agenesis (HP:0001592) | 2.63947609 |
| 18 | Trismus (HP:0000211) | 2.63406713 |
| 19 | Progressive muscle weakness (HP:0003323) | 2.63022925 |
| 20 | Hepatic necrosis (HP:0002605) | 2.60912233 |
| 21 | Nuclear cataract (HP:0100018) | 2.59438415 |
| 22 | Mitochondrial inheritance (HP:0001427) | 2.59089096 |
| 23 | Hypokinesia (HP:0002375) | 2.48665250 |
| 24 | Increased CSF lactate (HP:0002490) | 2.48564722 |
| 25 | Nemaline bodies (HP:0003798) | 2.45984251 |
| 26 | Achilles tendon contracture (HP:0001771) | 2.44501023 |
| 27 | Exercise intolerance (HP:0003546) | 2.44049753 |
| 28 | Short nail (HP:0001799) | 2.43833603 |
| 29 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.43103666 |
| 30 | Osteolytic defects of the hand bones (HP:0009699) | 2.43103666 |
| 31 | Type I transferrin isoform profile (HP:0003642) | 2.41658862 |
| 32 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.40863578 |
| 33 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.40863578 |
| 34 | Abnormality of glycolipid metabolism (HP:0010969) | 2.40863578 |
| 35 | Acute encephalopathy (HP:0006846) | 2.40228846 |
| 36 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.39298323 |
| 37 | Increased connective tissue (HP:0009025) | 2.37492747 |
| 38 | Abnormality of the umbilical cord (HP:0010881) | 2.33990565 |
| 39 | Hyperacusis (HP:0010780) | 2.33462308 |
| 40 | Slender build (HP:0001533) | 2.30325519 |
| 41 | Generalized amyotrophy (HP:0003700) | 2.29956826 |
| 42 | Abnormal trabecular bone morphology (HP:0100671) | 2.29161916 |
| 43 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.28041571 |
| 44 | Delayed gross motor development (HP:0002194) | 2.26202831 |
| 45 | Prolonged neonatal jaundice (HP:0006579) | 2.21978063 |
| 46 | Degeneration of anterior horn cells (HP:0002398) | 2.20455454 |
| 47 | Abnormality of the anterior horn cell (HP:0006802) | 2.20455454 |
| 48 | Wrist flexion contracture (HP:0001239) | 2.20279168 |
| 49 | Abnormal gallbladder physiology (HP:0012438) | 2.17537192 |
| 50 | Cholecystitis (HP:0001082) | 2.17537192 |
| 51 | Muscle fiber inclusion bodies (HP:0100299) | 2.17479133 |
| 52 | Abnormality of dentin (HP:0010299) | 2.17285138 |
| 53 | Microvesicular hepatic steatosis (HP:0001414) | 2.17216074 |
| 54 | Distal lower limb muscle weakness (HP:0009053) | 2.15767476 |
| 55 | Follicular hyperkeratosis (HP:0007502) | 2.15157222 |
| 56 | Exercise-induced muscle cramps (HP:0003710) | 2.14204120 |
| 57 | Ragged-red muscle fibers (HP:0003200) | 2.12385719 |
| 58 | Increased intramyocellular lipid droplets (HP:0012240) | 2.09938616 |
| 59 | Rhabdomyolysis (HP:0003201) | 2.05868161 |
| 60 | Increased serum lactate (HP:0002151) | 2.05705183 |
| 61 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.04786626 |
| 62 | Progressive macrocephaly (HP:0004481) | 2.04165684 |
| 63 | Wormian bones (HP:0002645) | 2.03913830 |
| 64 | Abnormality of the Achilles tendon (HP:0005109) | 2.02211004 |
| 65 | Delayed cranial suture closure (HP:0000270) | 2.01283742 |
| 66 | Muscle stiffness (HP:0003552) | 1.99442017 |
| 67 | Elbow flexion contracture (HP:0002987) | 1.98015278 |
| 68 | Lactic acidosis (HP:0003128) | 1.96681709 |
| 69 | Esophageal neoplasm (HP:0100751) | 1.94968310 |
| 70 | Neoplasm of head and neck (HP:0012288) | 1.94968310 |
| 71 | Respiratory failure (HP:0002878) | 1.94483593 |
| 72 | Abnormal protein glycosylation (HP:0012346) | 1.94414396 |
| 73 | Abnormal glycosylation (HP:0012345) | 1.94414396 |
| 74 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.94414396 |
| 75 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.94414396 |
| 76 | Myoglobinuria (HP:0002913) | 1.93197422 |
| 77 | Ulnar bowing (HP:0003031) | 1.93152521 |
| 78 | Cerebral edema (HP:0002181) | 1.92656702 |
| 79 | Overriding aorta (HP:0002623) | 1.91841039 |
| 80 | Fasciculations (HP:0002380) | 1.91471487 |
| 81 | Hypoplasia of the uterus (HP:0000013) | 1.91069854 |
| 82 | Renal Fanconi syndrome (HP:0001994) | 1.89958829 |
| 83 | Hydroureter (HP:0000072) | 1.87927169 |
| 84 | Broad distal phalanx of finger (HP:0009836) | 1.85435582 |
| 85 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.83938090 |
| 86 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.83285077 |
| 87 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.83285077 |
| 88 | Single umbilical artery (HP:0001195) | 1.83285077 |
| 89 | Bladder diverticulum (HP:0000015) | 1.82806222 |
| 90 | Facial cleft (HP:0002006) | 1.81559934 |
| 91 | Breast hypoplasia (HP:0003187) | 1.81468762 |
| 92 | Gout (HP:0001997) | 1.81460189 |
| 93 | Fragile skin (HP:0001030) | 1.80202681 |
| 94 | Limb-girdle muscle atrophy (HP:0003797) | 1.80195932 |
| 95 | Deformed tarsal bones (HP:0008119) | 1.79511264 |
| 96 | Increased hepatocellular lipid droplets (HP:0006565) | 1.78571623 |
| 97 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.78532124 |
| 98 | Limb-girdle muscle weakness (HP:0003325) | 1.77202470 |
| 99 | Multiple enchondromatosis (HP:0005701) | 1.76301195 |
| 100 | Adducted thumb (HP:0001181) | 1.75759339 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 3.90754787 |
| 2 | IRAK3 | 3.79941907 |
| 3 | NME2 | 3.49723326 |
| 4 | VRK2 | 3.35973087 |
| 5 | LIMK1 | 3.34929656 |
| 6 | ERBB4 | 3.32386665 |
| 7 | PBK | 3.13800265 |
| 8 | NEK1 | 2.78348782 |
| 9 | TTN | 2.72671110 |
| 10 | TESK1 | 2.60565474 |
| 11 | MST1R | 2.55318447 |
| 12 | ARAF | 2.18093378 |
| 13 | STK16 | 2.03746860 |
| 14 | MET | 1.89041945 |
| 15 | PAK4 | 1.85240346 |
| 16 | MYLK | 1.76169888 |
| 17 | CDC7 | 1.70394005 |
| 18 | TTK | 1.59005379 |
| 19 | CDK8 | 1.52775106 |
| 20 | EIF2AK1 | 1.47974506 |
| 21 | ABL2 | 1.42998891 |
| 22 | EPHB2 | 1.39400882 |
| 23 | PTK2 | 1.38788211 |
| 24 | BCKDK | 1.34981634 |
| 25 | BRSK1 | 1.33942658 |
| 26 | NTRK1 | 1.33577903 |
| 27 | MOS | 1.28938813 |
| 28 | TESK2 | 1.27837945 |
| 29 | SMG1 | 1.27305509 |
| 30 | BRAF | 1.25282598 |
| 31 | MAP3K12 | 1.20956965 |
| 32 | SRPK1 | 1.20674260 |
| 33 | PLK3 | 1.18923689 |
| 34 | PIM2 | 1.11506800 |
| 35 | FLT3 | 1.10249656 |
| 36 | AURKA | 1.04666938 |
| 37 | TSSK6 | 1.03838654 |
| 38 | PLK1 | 1.01973791 |
| 39 | ERN1 | 1.01703014 |
| 40 | CSNK1G3 | 1.00022122 |
| 41 | MAP3K9 | 0.98449924 |
| 42 | PDK2 | 0.96572667 |
| 43 | MAP3K8 | 0.96469372 |
| 44 | DAPK1 | 0.95550640 |
| 45 | LATS2 | 0.92246782 |
| 46 | DDR2 | 0.91513462 |
| 47 | CAMK2G | 0.90679867 |
| 48 | CHEK2 | 0.90023600 |
| 49 | AURKB | 0.85572316 |
| 50 | KDR | 0.85012493 |
| 51 | WEE1 | 0.82029281 |
| 52 | PDGFRA | 0.80862577 |
| 53 | CSNK1A1L | 0.80119574 |
| 54 | EPHA2 | 0.77246253 |
| 55 | CSNK1G1 | 0.75853129 |
| 56 | MST4 | 0.75036493 |
| 57 | ZAK | 0.74655766 |
| 58 | VRK1 | 0.68987192 |
| 59 | TRIM28 | 0.68780807 |
| 60 | PAK2 | 0.68310748 |
| 61 | PRKCI | 0.67295124 |
| 62 | PAK1 | 0.66471034 |
| 63 | PLK2 | 0.62247141 |
| 64 | MAPKAPK3 | 0.60905656 |
| 65 | CDK7 | 0.59581066 |
| 66 | BRSK2 | 0.59082619 |
| 67 | DAPK3 | 0.58254473 |
| 68 | EIF2AK3 | 0.57088988 |
| 69 | PAK6 | 0.56651897 |
| 70 | STK10 | 0.56219627 |
| 71 | TGFBR2 | 0.55968632 |
| 72 | MAP3K3 | 0.55914346 |
| 73 | PHKG2 | 0.54821590 |
| 74 | PHKG1 | 0.54821590 |
| 75 | IRAK2 | 0.54821087 |
| 76 | AKT2 | 0.54435941 |
| 77 | CSNK1G2 | 0.51503042 |
| 78 | BCR | 0.50938224 |
| 79 | CAMK2D | 0.46794640 |
| 80 | NEK2 | 0.45725072 |
| 81 | MELK | 0.44527799 |
| 82 | MAPK11 | 0.43731612 |
| 83 | TAOK2 | 0.42778747 |
| 84 | CDK14 | 0.42722858 |
| 85 | ADRBK2 | 0.41887897 |
| 86 | ILK | 0.40881003 |
| 87 | STK4 | 0.39946150 |
| 88 | ATR | 0.38636066 |
| 89 | CLK1 | 0.38159496 |
| 90 | CDK18 | 0.37835378 |
| 91 | GRK5 | 0.37044424 |
| 92 | CDK11A | 0.36935408 |
| 93 | ADRBK1 | 0.36648687 |
| 94 | CDK15 | 0.36307291 |
| 95 | MAP3K11 | 0.35510992 |
| 96 | BMX | 0.35057005 |
| 97 | PLK4 | 0.34380829 |
| 98 | CAMK2B | 0.34089029 |
| 99 | STK38 | 0.32818814 |
| 100 | CHEK1 | 0.32348510 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.38077794 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.35194524 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 2.72476731 |
| 4 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.68505220 |
| 5 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.43557942 |
| 6 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.23364095 |
| 7 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.18280159 |
| 8 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.15129849 |
| 9 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.08537920 |
| 10 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.04756757 |
| 11 | Base excision repair_Homo sapiens_hsa03410 | 2.03454780 |
| 12 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 2.00459203 |
| 13 | Parkinsons disease_Homo sapiens_hsa05012 | 2.00198926 |
| 14 | Carbon metabolism_Homo sapiens_hsa01200 | 1.94294590 |
| 15 | Ribosome_Homo sapiens_hsa03010 | 1.92799544 |
| 16 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.89866312 |
| 17 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.88837954 |
| 18 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.84045222 |
| 19 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.80155539 |
| 20 | Sulfur relay system_Homo sapiens_hsa04122 | 1.75739586 |
| 21 | RNA polymerase_Homo sapiens_hsa03020 | 1.73018358 |
| 22 | * Galactose metabolism_Homo sapiens_hsa00052 | 1.72599584 |
| 23 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.65263457 |
| 24 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.64883432 |
| 25 | Protein export_Homo sapiens_hsa03060 | 1.59035555 |
| 26 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.58175866 |
| 27 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.57751460 |
| 28 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.56255123 |
| 29 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.55787757 |
| 30 | Homologous recombination_Homo sapiens_hsa03440 | 1.50815972 |
| 31 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.50175545 |
| 32 | Huntingtons disease_Homo sapiens_hsa05016 | 1.49121737 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.40109918 |
| 34 | Alzheimers disease_Homo sapiens_hsa05010 | 1.38109068 |
| 35 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.36676038 |
| 36 | * Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.33844252 |
| 37 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.25187210 |
| 38 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.22864321 |
| 39 | Cell cycle_Homo sapiens_hsa04110 | 1.18469916 |
| 40 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.17914334 |
| 41 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.15874575 |
| 42 | Spliceosome_Homo sapiens_hsa03040 | 1.13568147 |
| 43 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.12939914 |
| 44 | RNA transport_Homo sapiens_hsa03013 | 1.10554726 |
| 45 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.08936033 |
| 46 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.03989490 |
| 47 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.03433692 |
| 48 | Bladder cancer_Homo sapiens_hsa05219 | 1.03127126 |
| 49 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.98806580 |
| 50 | Purine metabolism_Homo sapiens_hsa00230 | 0.96448977 |
| 51 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.95612892 |
| 52 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.95452418 |
| 53 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.93235078 |
| 54 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.92026189 |
| 55 | * Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.91450205 |
| 56 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.87858200 |
| 57 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.80060338 |
| 58 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.80034197 |
| 59 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.77350393 |
| 60 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.75890001 |
| 61 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.73402581 |
| 62 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.71821569 |
| 63 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.70471234 |
| 64 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.70202980 |
| 65 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.69055163 |
| 66 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.66653328 |
| 67 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.66316355 |
| 68 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.65764265 |
| 69 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.65187614 |
| 70 | Lysosome_Homo sapiens_hsa04142 | 0.64217990 |
| 71 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.60512010 |
| 72 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.60369186 |
| 73 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.58581118 |
| 74 | Basal transcription factors_Homo sapiens_hsa03022 | 0.55314999 |
| 75 | Shigellosis_Homo sapiens_hsa05131 | 0.54322655 |
| 76 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.53019802 |
| 77 | RNA degradation_Homo sapiens_hsa03018 | 0.51229701 |
| 78 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.48721430 |
| 79 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.47698376 |
| 80 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.45987240 |
| 81 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.44006071 |
| 82 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.42814611 |
| 83 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.42295619 |
| 84 | Focal adhesion_Homo sapiens_hsa04510 | 0.41110000 |
| 85 | Prion diseases_Homo sapiens_hsa05020 | 0.40819209 |
| 86 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.39006749 |
| 87 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.38299399 |
| 88 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.38071572 |
| 89 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.37385013 |
| 90 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.35729143 |
| 91 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.33929320 |
| 92 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.33213511 |
| 93 | Other glycan degradation_Homo sapiens_hsa00511 | 0.33160391 |
| 94 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.33038964 |
| 95 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.31138143 |
| 96 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.29372177 |
| 97 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.26204293 |
| 98 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.23133619 |
| 99 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.21832328 |
| 100 | Thyroid cancer_Homo sapiens_hsa05216 | 0.21722739 |

